Commentary: The Dilemma of Unmodified Electroconvulsive Therapy
J Clin Psychiatry 2003;64:1147-1152
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece does not
have an abstract, we have provided for your benefit the first 3 sentences
of the full text.
Electroconvulsive therapy (ECT) was introduced in
1938, in an era in which antidepressant and antipsychotic
drugs were unknown.1,2
Today, over 6 decades later, despite the availability of a large number of psychopharmacologic agents for the treatment of depression and psychosis, ECT remains an important method of treatment in
psychiatry. This is because ECT can be life-saving in catatonic, suicidal, or otherwise severely disturbed patients,2
because it is of exceptional benefit to patients with psychotic depression,3
and because it can be therapeutic4–6
well as prophylactic7
in patients who do not respond to
antidepressant or antipsychotic drugs.